Latest Breaking News On - Global health technology fund - Page 1 : vimarsana.com

Global health leaders adopt the Nagasaki Outcomes Statement and jointly call for the acceleration of R&D, access and delivery for neglected tropical diseases

/PRNewswire/ Today, leading organizations signed and adopted the "Nagasaki Outcomes Statement," which calls for accelerated R&D, access and delivery for.

Katy lenardMasanori komedaFumio kishidaEriko mugitani mina ohataPompe van meerdervoortJapan pharmaceutical manufacturers associationProgramme for researchHealth ministers meeting in nagasakiNagasaki universityMedicines development for global healthNagasaki medical collegeEisai co ltdSustainable development goalsSustainable development goals sdgsAccess campaignMelinda gates foundation

Africa: Global Health Leaders Adopt the Nagasaki Outcomes Statement and Jointly Call For the Acceleration of R&D, Access, and Delivery for Neglected Tropical Diseases

Africa: Global Health Leaders Adopt the Nagasaki Outcomes Statement and Jointly Call For the Acceleration of R&D, Access, and Delivery for Neglected Tropical Diseases
allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.

Fumio kishidaPompe van meerdervoortMerck kgaaEisai co ltdAstellas pharma incJapan alliance on global ntds jagntdUnited nations development programmeProgramme for researchMelinda gates foundationJapan pharmaceutical manufacturers associationGlobal health innovation alliance acceleratorMerck kgaHealth coverageGlobal health innovative technology fundHealth ministers meeting in nagasaki accelerating researchSustainable development goals sdgs

Standigm and Institut Pasteur Korea Collaborate for AI-Based Study

Standigm, a prominent workflow artificial intelligence (AI) drug discovery company, recently signed a Memorandum of Understanding (MOU) with Institut Pasteur Korea (IPK), the infectious disease-focused research organization contributing to public health, for AI-based drug discovery study for infectious disease.

South koreaAlex smithJinhan kimYoungmee jeeFund technical accelerator awardResearch investment for global health technology fundMinistry of healthMelinda gates foundationBethan daviesdecInstitut pasteur koreaInstitut pasteur korea collaborateBased studyImage creditResearch investmentGlobal health technology fund

Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease

- Combine Standigm's AI drug discovery platform and Institut Pasteur Korea's research expertise in infectious disease - Accelerate discovery of novel anti-tubercular drug candidates by conducting RIGHT Fund's awarded projects SEOUL, South Korea, Nov. 30, 2021 /PRNewswire/ Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the signing of a Memorandum of Understanding.

Soult ukpyolsiSouth koreaUnited kingdomSangah leeYoungmee jeeJinhan kimPasteur networkPrnewswire standigm incFund technical accelerator awardResearch investment for global health technology fundMinistry of healthMelinda gates foundationInstitut pasteur koreaResearch investmentGlobal health technology fundPasteur korea

Biological engineers find a new target for malaria drugs

Every year, more than 200 million people are infected with malaria, and nearly 500,000 die from the disease. Existing drugs can treat the infection, but

Jacquin nilesRobert summersJoao piscoAmanda lukensBeatriz baraganaCharisse flerida pasajeBroad instituteGlobal health technology fundMelinda gates foundationEnvironmental health sciencesGates foundationUniversity of dundeeDyann wirthRichard pearson strong professorInfectious diseasePublic health